JP2019518084A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019518084A5 JP2019518084A5 JP2019518350A JP2019518350A JP2019518084A5 JP 2019518084 A5 JP2019518084 A5 JP 2019518084A5 JP 2019518350 A JP2019518350 A JP 2019518350A JP 2019518350 A JP2019518350 A JP 2019518350A JP 2019518084 A5 JP2019518084 A5 JP 2019518084A5
- Authority
- JP
- Japan
- Prior art keywords
- topical formulation
- histidine
- formulation according
- skin
- nucleophile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012049 topical pharmaceutical composition Substances 0.000 claims 18
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 10
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 9
- 208000003251 Pruritus Diseases 0.000 claims 4
- 239000012038 nucleophile Substances 0.000 claims 4
- 201000004624 Dermatitis Diseases 0.000 claims 3
- 235000001014 amino acid Nutrition 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims 2
- 206010013786 Dry skin Diseases 0.000 claims 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 2
- 239000004202 carbamide Substances 0.000 claims 2
- 230000037336 dry skin Effects 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 claims 2
- 239000004475 Arginine Substances 0.000 claims 1
- 102100028314 Filaggrin Human genes 0.000 claims 1
- 101710088660 Filaggrin Proteins 0.000 claims 1
- 206010021639 Incontinence Diseases 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- 206010060875 Uraemic pruritus Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000032683 aging Effects 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 230000002950 deficient Effects 0.000 claims 1
- 239000007857 degradation product Substances 0.000 claims 1
- 230000000269 nucleophilic effect Effects 0.000 claims 1
- DQAKJEWZWDQURW-UHFFFAOYSA-N pyrrolidonecarboxylic acid Chemical class OC(=O)N1CCCC1=O DQAKJEWZWDQURW-UHFFFAOYSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 159000000000 sodium salts Chemical class 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022014925A JP7220316B2 (ja) | 2016-06-17 | 2022-02-02 | 尿毒症性掻痒症の治療に使用するための製剤 |
| JP2022173435A JP2022187022A (ja) | 2016-06-17 | 2022-10-28 | 尿毒症性掻痒症の治療に使用するための製剤 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201670438 | 2016-06-17 | ||
| DKPA201670438 | 2016-06-17 | ||
| DKPA201770225 | 2017-03-28 | ||
| DKPA201770225 | 2017-03-28 | ||
| PCT/DK2017/050201 WO2017215723A1 (en) | 2016-06-17 | 2017-06-16 | Formulation for use in the treatment of uremic pruritus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022014925A Division JP7220316B2 (ja) | 2016-06-17 | 2022-02-02 | 尿毒症性掻痒症の治療に使用するための製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019518084A JP2019518084A (ja) | 2019-06-27 |
| JP2019518084A5 true JP2019518084A5 (cg-RX-API-DMAC7.html) | 2020-07-27 |
| JP7019684B2 JP7019684B2 (ja) | 2022-02-15 |
Family
ID=60663348
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019518350A Active JP7019684B2 (ja) | 2016-06-17 | 2017-06-16 | 尿毒症性掻痒症の治療に使用するための製剤 |
| JP2022014925A Active JP7220316B2 (ja) | 2016-06-17 | 2022-02-02 | 尿毒症性掻痒症の治療に使用するための製剤 |
| JP2022173435A Pending JP2022187022A (ja) | 2016-06-17 | 2022-10-28 | 尿毒症性掻痒症の治療に使用するための製剤 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022014925A Active JP7220316B2 (ja) | 2016-06-17 | 2022-02-02 | 尿毒症性掻痒症の治療に使用するための製剤 |
| JP2022173435A Pending JP2022187022A (ja) | 2016-06-17 | 2022-10-28 | 尿毒症性掻痒症の治療に使用するための製剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10806721B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3471720B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7019684B2 (cg-RX-API-DMAC7.html) |
| KR (3) | KR102454777B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN109414430B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2017283511B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112018076229A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3026620C (cg-RX-API-DMAC7.html) |
| ES (1) | ES3006940T3 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2018146294A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017215723A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102454777B1 (ko) * | 2016-06-17 | 2022-10-14 | 드러그 딜리버리 솔루션즈 에이피에스 | 요독 가려움증의 치료에 사용하기 위한 제형 |
| WO2023194400A1 (en) * | 2022-04-06 | 2023-10-12 | Mc2 Therapeutics Ltd | Topical formulation for use in the treatment or prevention of itchy dry skin |
| EP4681722A1 (en) * | 2024-07-18 | 2026-01-21 | Institut National de la Santé et de la Recherche Médicale | Methods for the treatment of inflammatory skin diseases with urocanase inhibitor |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4025645A (en) | 1976-01-27 | 1977-05-24 | Jelenko Iii Carl | Non-steroid topical agent for alleviating inflammation in mammals |
| US5811446A (en) | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
| US6573302B1 (en) | 1999-09-29 | 2003-06-03 | Medical Merchandising, Inc. | Cream utilizing capsaicin |
| US20060211754A1 (en) | 2005-03-16 | 2006-09-21 | Yu Ruey J | Compositions comprising N-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof |
| US20070065396A1 (en) | 2005-09-21 | 2007-03-22 | Tracie Martyn International, Llc | Topical macqui berry formulation |
| JP5168996B2 (ja) * | 2007-04-13 | 2013-03-27 | 味の素株式会社 | アミノ酸類高配合防腐水溶液 |
| FR2916351B1 (fr) | 2007-05-22 | 2012-12-07 | Galderma Res & Dev | Composition pharmaceutique comprenant au moins deux composes choisis parmi l'acide pyrrolidone-5-carboxylique, la citrulline, l'arginine et l'asparagine et leur utilisation dans le traitement de la dermatite atopique |
| US20090017129A1 (en) | 2007-07-13 | 2009-01-15 | Ma Or Ze Ev | Dead Sea minerals enriched anti-inflammatory pharmaceutical composition for treatment of cutaneous dryness, itching, peeling and tightness, especially in hemodialysis patients and preparation and treatment methods thereof |
| US8337820B2 (en) | 2008-02-13 | 2012-12-25 | Bart Nieuwenhuijsen | Composition of a water-soluble sunscreen preparation for acne rosacea |
| GB0803054D0 (en) | 2008-02-20 | 2008-03-26 | Univ Manchester | Medicament |
| EP2373583A1 (en) | 2008-07-23 | 2011-10-12 | Fze Engsl | A combined solid waste, carbon dioxide quicklime sparging, brine water, and reverse osmosis/ion exchange processes for the production of soda chemicals |
| FR2938193B1 (fr) * | 2008-11-07 | 2011-08-12 | Expanscience Lab | Medicament ou composition dermatologique comprenant un extrait peptidique d'avocat destine au traitement et a la prevention du prupit |
| NZ595775A (en) | 2008-12-26 | 2013-07-26 | Glenmark Pharmaceuticals Sa | Fused imidazole derivatives as trpv3 antagonist |
| KR100953515B1 (ko) * | 2009-08-28 | 2010-04-21 | 전북대학교산학협력단 | 피부 가려움증 개선을 위한 조성물 |
| DE102011110909A1 (de) * | 2011-08-18 | 2013-02-21 | Paul Hartmann Ag | Zusammensetzungen mit einer die Hautbarriere verbessernden Wirkstoffkombination |
| EP2869897A4 (en) * | 2012-07-06 | 2016-09-28 | Univ Duke | ACTIVATION OF THE TRPV4 ION CHANNEL BY PHYSICAL STIMULI AND IMPORTANT ROLE FOR TRPV4 IN ORGANIC INFLAMMATION AND JUCKREIZ |
| US20160008297A1 (en) | 2012-08-23 | 2016-01-14 | B.R.A.I.N. Biotechnology Research And Information Network Ag | Compounds for preventing, reducing and/or alleviating itchy skin condition(s) |
| CN103908467B (zh) * | 2013-01-05 | 2017-02-08 | 西藏博睿生物科技有限公司 | 一种药物组合物及制剂 |
| WO2016086280A1 (pt) * | 2014-12-04 | 2016-06-09 | Cardoso De Gouveia Alberto | Composição dermatológica e seu uso |
| KR102454777B1 (ko) | 2016-06-17 | 2022-10-14 | 드러그 딜리버리 솔루션즈 에이피에스 | 요독 가려움증의 치료에 사용하기 위한 제형 |
-
2017
- 2017-06-16 KR KR1020197000483A patent/KR102454777B1/ko active Active
- 2017-06-16 ES ES17812796T patent/ES3006940T3/es active Active
- 2017-06-16 CN CN201780042643.4A patent/CN109414430B/zh active Active
- 2017-06-16 AU AU2017283511A patent/AU2017283511B2/en active Active
- 2017-06-16 EP EP17812796.5A patent/EP3471720B1/en active Active
- 2017-06-16 RU RU2018146294A patent/RU2018146294A/ru unknown
- 2017-06-16 KR KR1020247020977A patent/KR20240100484A/ko not_active Ceased
- 2017-06-16 JP JP2019518350A patent/JP7019684B2/ja active Active
- 2017-06-16 EP EP24178043.6A patent/EP4397368A3/en active Pending
- 2017-06-16 BR BR112018076229-6A patent/BR112018076229A2/pt not_active Application Discontinuation
- 2017-06-16 CA CA3026620A patent/CA3026620C/en active Active
- 2017-06-16 US US16/310,025 patent/US10806721B2/en active Active
- 2017-06-16 WO PCT/DK2017/050201 patent/WO2017215723A1/en not_active Ceased
- 2017-06-16 CN CN202211256647.1A patent/CN115671098A/zh active Pending
- 2017-06-16 KR KR1020227035218A patent/KR20220143149A/ko not_active Ceased
-
2020
- 2020-04-27 AU AU2020202785A patent/AU2020202785B2/en active Active
- 2020-09-18 US US17/025,548 patent/US20210000796A1/en not_active Abandoned
-
2022
- 2022-02-02 JP JP2022014925A patent/JP7220316B2/ja active Active
- 2022-10-28 JP JP2022173435A patent/JP2022187022A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2925876T3 (es) | Nuevo tratamiento de las úlceras crónicas | |
| HRP20200434T1 (hr) | Stabilne vodene formulacije adalimumaba | |
| CN108136027A (zh) | 用于活性成分的基于凡士林的递送系统 | |
| JP2012236857A5 (cg-RX-API-DMAC7.html) | ||
| MX374287B (es) | Formulacion que contiene virus y uso de la misma. | |
| JP2011529038A5 (cg-RX-API-DMAC7.html) | ||
| JP2009519940A (ja) | 皮膚科学的状態を処置するための組成物および方法 | |
| RU2014142038A (ru) | Короткие антимикробные липопептиды | |
| JP2015512403A5 (cg-RX-API-DMAC7.html) | ||
| US20080299228A1 (en) | Topical compositions comprising a macromolecule and methods of using same | |
| JP2010536745A5 (cg-RX-API-DMAC7.html) | ||
| SA517390331B1 (ar) | تراكيب مصفوفة بوليمر موضعية تشتمل على تركيز عالي من هيالورونات الصوديوم المخمر حيوياً واستخداماتها | |
| JP2021536502A (ja) | アミノ酸ベースの栄養素の使用及びそれを含む医薬組成物 | |
| MX2013004099A (es) | Conjunto de juguete de construccion. | |
| AR065317A1 (es) | Uso de quitosanos, derivados de quitosanos y una sal fisiologicamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales | |
| MY191712A (en) | Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation | |
| BR112015020443A8 (pt) | formulação em pó para inalação, seus usos e seu processo de preparação, e composição farmacêutica | |
| RU2018146294A (ru) | Композиция для лечения уремического зуда | |
| NZ719321A (en) | Storage stable lyophilized tripeptide formulations | |
| WO2016079246A1 (en) | Bioadhesive films | |
| WO2019004788A3 (ko) | 브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물 | |
| WO2015100348A8 (en) | Keloid reduction using topical allantoin | |
| WO2020170033A8 (en) | Method for treatment of moderate to severe erythema symptoms in rosacea patients | |
| KR20260030114A (ko) | 신규한 다기능성 올리고펩타이드 | |
| WO2012140609A3 (en) | System for prolonged release of cosmetic agents |